The University of Chicago Header Logo

Mark Talamonti

Concepts (729)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
85
2023
645
10.270
Why?
Pancreatectomy
37
2023
148
4.450
Why?
Psoriasis
14
2020
240
4.360
Why?
Adenocarcinoma
45
2019
1169
3.910
Why?
Pancreaticoduodenectomy
24
2023
81
3.390
Why?
Carcinoma, Pancreatic Ductal
21
2022
108
2.970
Why?
Dermatologic Agents
7
2019
71
2.470
Why?
Liver Neoplasms
16
2023
736
1.750
Why?
Laparoscopy
18
2023
754
1.730
Why?
HLA-C Antigens
3
2017
21
1.640
Why?
Aged
110
2023
18407
1.600
Why?
Antibodies, Monoclonal, Humanized
12
2021
931
1.570
Why?
Ustekinumab
4
2019
47
1.540
Why?
Middle Aged
113
2023
25027
1.500
Why?
Neuroendocrine Tumors
9
2023
105
1.470
Why?
Neoplasm Staging
33
2018
1938
1.350
Why?
Humans
200
2023
86656
1.290
Why?
Antibodies, Monoclonal
9
2018
1380
1.280
Why?
Bile Duct Neoplasms
4
2021
79
1.220
Why?
Postoperative Complications
20
2023
2204
1.200
Why?
Pancreatic Fistula
7
2023
16
1.200
Why?
Male
123
2023
40995
1.190
Why?
Robotic Surgical Procedures
9
2023
267
1.170
Why?
Female
124
2023
44566
1.140
Why?
Carcinoma
7
2012
436
1.130
Why?
Retrospective Studies
60
2023
8476
1.120
Why?
Colorectal Neoplasms
13
2023
938
1.060
Why?
Biliary Tract Neoplasms
3
2012
33
1.050
Why?
Treatment Outcome
50
2023
7982
1.050
Why?
Interleukin-17
3
2020
101
1.010
Why?
Venous Thromboembolism
3
2023
152
0.950
Why?
Deoxycytidine
10
2018
237
0.940
Why?
Ampulla of Vater
4
2014
22
0.900
Why?
Adult
63
2023
25648
0.860
Why?
Antineoplastic Combined Chemotherapy Protocols
15
2023
2438
0.840
Why?
Aged, 80 and over
37
2021
6511
0.830
Why?
Portal Vein
2
2021
119
0.800
Why?
Hepatectomy
8
2023
166
0.800
Why?
Endosonography
3
2015
96
0.790
Why?
Pancreatic Diseases
4
2020
51
0.790
Why?
Survival Analysis
25
2017
1540
0.770
Why?
Neoadjuvant Therapy
11
2016
318
0.760
Why?
Pancreatic Cyst
5
2009
28
0.760
Why?
Rectal Neoplasms
5
2007
116
0.760
Why?
Thrombosis
2
2023
296
0.740
Why?
General Surgery
2
2022
229
0.740
Why?
Biological Therapy
1
2020
46
0.730
Why?
Organizational Innovation
2
2020
41
0.720
Why?
Drug Eruptions
1
2020
35
0.710
Why?
Stents
4
2021
377
0.700
Why?
Acrodermatitis
1
2019
3
0.700
Why?
Societies, Medical
3
2020
573
0.680
Why?
Venous Thrombosis
1
2021
243
0.660
Why?
Severity of Illness Index
10
2021
1804
0.660
Why?
Diffusion of Innovation
1
2019
71
0.660
Why?
Surgical Wound Infection
4
2023
182
0.650
Why?
Stomach Neoplasms
5
2016
266
0.650
Why?
Adalimumab
2
2018
80
0.640
Why?
Endovascular Procedures
1
2021
218
0.640
Why?
Postoperative Hemorrhage
3
2017
46
0.640
Why?
Length of Stay
9
2023
704
0.610
Why?
Drainage
3
2015
157
0.600
Why?
Survival Rate
24
2018
1864
0.600
Why?
Prognosis
26
2016
3681
0.590
Why?
Lymph Node Excision
8
2016
217
0.590
Why?
Cholangiocarcinoma
4
2021
66
0.580
Why?
Colonic Neoplasms
9
2021
557
0.570
Why?
Dermatitis, Atopic
2
2021
52
0.570
Why?
Preoperative Care
8
2017
397
0.550
Why?
Alleles
2
2017
1129
0.550
Why?
Pancreatitis
5
2015
87
0.550
Why?
Adenocarcinoma, Mucinous
2
2007
48
0.540
Why?
Education, Medical
1
2019
234
0.540
Why?
Learning
1
2019
281
0.540
Why?
Pancreas
8
2023
239
0.530
Why?
Intestinal Neoplasms
2
2009
56
0.530
Why?
Risk Factors
23
2023
5416
0.520
Why?
Biomarkers, Tumor
11
2014
1464
0.520
Why?
Mass Screening
2
2015
619
0.510
Why?
Chemotherapy, Adjuvant
15
2017
468
0.510
Why?
Antimetabolites, Antineoplastic
6
2018
236
0.510
Why?
Radiotherapy, Adjuvant
12
2018
292
0.500
Why?
Mesenteric Veins
4
2021
34
0.500
Why?
Regional Health Planning
2
2014
13
0.500
Why?
Embolization, Therapeutic
2
2014
238
0.500
Why?
Registries
6
2017
703
0.490
Why?
Hepatic Artery
1
2014
82
0.480
Why?
Surgery, Computer-Assisted
1
2015
97
0.470
Why?
Cornified Envelope Proline-Rich Proteins
1
2013
6
0.470
Why?
Carcinoma, Papillary
4
2007
158
0.460
Why?
Combined Modality Therapy
16
2016
1686
0.460
Why?
Patient Readmission
4
2017
329
0.450
Why?
Databases, Factual
10
2017
816
0.430
Why?
Prospective Studies
10
2023
4212
0.420
Why?
United States
28
2023
6674
0.420
Why?
Proportional Hazards Models
11
2017
860
0.420
Why?
Barrett Esophagus
5
2018
93
0.420
Why?
Early Detection of Cancer
2
2015
395
0.410
Why?
Cohort Studies
11
2020
2765
0.410
Why?
Quality Indicators, Health Care
2
2010
145
0.410
Why?
Radiotherapy, Conformal
2
2011
83
0.400
Why?
Safety-Based Drug Withdrawals
1
2011
2
0.400
Why?
Lymph Nodes
7
2016
533
0.390
Why?
Young Adult
12
2021
5977
0.370
Why?
Esophageal Neoplasms
8
2018
322
0.370
Why?
Carcinoma, Hepatocellular
3
2018
386
0.370
Why?
Withholding Treatment
1
2011
112
0.370
Why?
SEER Program
3
2014
190
0.360
Why?
Carcinoid Tumor
4
2002
42
0.360
Why?
Health Care Costs
2
2017
238
0.360
Why?
Surgeons
3
2023
233
0.360
Why?
Follow-Up Studies
16
2018
3639
0.360
Why?
Quality of Health Care
2
2010
381
0.350
Why?
Intestine, Small
2
2009
302
0.330
Why?
Logistic Models
9
2020
1185
0.330
Why?
Neoplasm, Residual
2
2016
162
0.320
Why?
Endoscopy, Gastrointestinal
2
2018
153
0.320
Why?
Multivariate Analysis
9
2019
999
0.320
Why?
Angiogenesis Inhibitors
1
2010
311
0.310
Why?
Hospitals, Veterans
1
2007
17
0.310
Why?
Hospital Bed Capacity
1
2007
20
0.310
Why?
Age Factors
5
2018
1849
0.300
Why?
Minimally Invasive Surgical Procedures
5
2023
237
0.300
Why?
Neoplasms
8
2023
2898
0.300
Why?
DNA-Binding Proteins
1
2013
1214
0.300
Why?
Incidence
10
2022
1578
0.300
Why?
Hospitals
5
2019
294
0.290
Why?
Patient Selection
4
2014
686
0.280
Why?
Cholangitis
1
2006
19
0.280
Why?
Hospital Costs
3
2017
107
0.270
Why?
Time Factors
9
2018
5215
0.270
Why?
Fluorouracil
10
2023
556
0.270
Why?
Diagnostic Techniques and Procedures
1
2005
24
0.270
Why?
Gastrectomy
2
2016
68
0.260
Why?
Delivery of Health Care
1
2010
426
0.260
Why?
Disposable Equipment
2
2015
19
0.260
Why?
Skin
2
2020
554
0.250
Why?
Risk Assessment
5
2019
2261
0.250
Why?
CA-19-9 Antigen
3
2014
11
0.250
Why?
Hospitals, Community
3
2010
32
0.240
Why?
Gallbladder Neoplasms
2
2020
22
0.240
Why?
Insurance Claim Review
1
2004
41
0.240
Why?
MicroRNAs
2
2023
535
0.240
Why?
Drug Administration Schedule
6
2017
915
0.230
Why?
Rectum
1
2004
146
0.230
Why?
Liver Transplantation
3
2018
1271
0.230
Why?
Cefoxitin
1
2023
3
0.230
Why?
Esophagectomy
3
2012
84
0.230
Why?
Biliary Tract Surgical Procedures
1
2023
11
0.230
Why?
Chemoradiotherapy
3
2016
301
0.230
Why?
Internship and Residency
2
2023
1010
0.230
Why?
Rectus Abdominis
2
2017
37
0.230
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2023
16
0.220
Why?
Benzoates
4
2007
44
0.220
Why?
Mortality
1
2004
150
0.220
Why?
Immunosuppressive Agents
3
2021
977
0.210
Why?
Bevacizumab
3
2018
281
0.210
Why?
Diagnosis, Differential
6
2015
1564
0.210
Why?
Neoplasm Metastasis
5
2013
1056
0.210
Why?
Cecal Neoplasms
1
2002
5
0.210
Why?
Biliary Tract Diseases
1
2022
34
0.210
Why?
Chronic Disease
3
2020
972
0.210
Why?
Anus Neoplasms
3
2011
30
0.210
Why?
Ileal Neoplasms
1
2002
9
0.210
Why?
Common Bile Duct Neoplasms
1
2001
6
0.210
Why?
Endoscopy, Digestive System
2
2012
65
0.210
Why?
Genotype
2
2017
1853
0.200
Why?
Simulation Training
1
2023
88
0.200
Why?
Algorithms
4
2018
1830
0.200
Why?
Italy
2
2020
106
0.200
Why?
Situs Inversus
1
2001
13
0.200
Why?
Bile Ducts, Extrahepatic
2
2012
12
0.200
Why?
Gastric Bypass
1
2023
110
0.200
Why?
Chemoradiotherapy, Adjuvant
3
2018
35
0.200
Why?
Gene Expression Regulation, Neoplastic
6
2010
1197
0.200
Why?
Infliximab
3
2018
151
0.200
Why?
Obesity, Morbid
2
2023
225
0.200
Why?
Eczema
1
2021
7
0.200
Why?
Anastomosis, Surgical
5
2016
267
0.190
Why?
Palliative Care
5
2007
257
0.190
Why?
Sigmoidoscopy
1
2001
36
0.190
Why?
Tomography, X-Ray Computed
8
2017
2585
0.190
Why?
Models, Theoretical
1
2004
482
0.190
Why?
Nurse Practitioners
1
2001
32
0.190
Why?
Adolescent
12
2021
8988
0.190
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2020
57
0.190
Why?
Cell Cycle
3
2007
503
0.190
Why?
Etanercept
2
2018
32
0.190
Why?
Drug Substitution
2
2018
25
0.180
Why?
Thyroid Neoplasms
4
2020
408
0.180
Why?
Europe
2
2019
309
0.180
Why?
Genetic Markers
3
2017
477
0.180
Why?
Biological Products
2
2013
143
0.180
Why?
Surgical Oncology
1
2020
27
0.180
Why?
Robotics
1
2023
267
0.180
Why?
Cystic Fibrosis
1
2020
112
0.180
Why?
Gastrointestinal Neoplasms
3
2001
106
0.180
Why?
Emergencies
1
2020
113
0.180
Why?
Chemoembolization, Therapeutic
4
2009
36
0.180
Why?
Colonic Polyps
2
2008
127
0.180
Why?
Personnel Selection
1
2020
59
0.180
Why?
Cancer Care Facilities
2
2010
28
0.180
Why?
Neoplasm Invasiveness
6
2012
552
0.170
Why?
Cell Proliferation
6
2008
1596
0.170
Why?
Sepsis
1
2023
307
0.170
Why?
Lymphatic Metastasis
8
2008
486
0.170
Why?
Specialties, Surgical
1
2020
64
0.170
Why?
Fellowships and Scholarships
1
2020
110
0.170
Why?
Kaplan-Meier Estimate
5
2018
861
0.170
Why?
Interviews as Topic
1
2020
319
0.170
Why?
Arachidonate 5-Lipoxygenase
3
2008
22
0.170
Why?
User-Computer Interface
1
2020
185
0.170
Why?
Steroids
1
2020
176
0.170
Why?
Neoplasm Recurrence, Local
6
2014
1313
0.160
Why?
Yttrium Radioisotopes
2
2009
46
0.160
Why?
Propensity Score
4
2020
136
0.160
Why?
Education, Medical, Continuing
2
2015
107
0.160
Why?
Carcinoma, Ductal, Breast
2
1997
157
0.160
Why?
Conversion to Open Surgery
1
2018
11
0.160
Why?
Adenoma
3
2008
237
0.160
Why?
Comorbidity
3
2021
945
0.160
Why?
Radiotherapy
4
2012
328
0.160
Why?
Mutation
4
2023
3977
0.160
Why?
Gene Expression Profiling
3
2018
1387
0.160
Why?
Thyroidectomy
3
2007
170
0.160
Why?
Gene Amplification
1
2018
131
0.160
Why?
Carcinoma in Situ
2
2005
53
0.150
Why?
Reoperation
3
2017
593
0.150
Why?
Liver
2
2017
1229
0.150
Why?
Databases as Topic
2
2007
92
0.150
Why?
Receptors, Calcitriol
1
2018
129
0.150
Why?
Nuclear Proteins
2
1999
705
0.150
Why?
Predictive Value of Tests
5
2014
1672
0.150
Why?
Stromal Cells
2
2015
143
0.150
Why?
Evidence-Based Medicine
1
2020
429
0.150
Why?
Laparotomy
1
2017
58
0.150
Why?
Receptors, Interleukin-17
1
2016
10
0.150
Why?
Incidental Findings
1
2017
95
0.150
Why?
Dyslipidemias
1
2018
109
0.150
Why?
Abdominal Wall
1
2017
30
0.150
Why?
Pylorus
2
2007
14
0.150
Why?
Muscular Atrophy
1
2017
41
0.140
Why?
Stomach
2
2012
108
0.140
Why?
Metabolic Syndrome
1
2018
142
0.140
Why?
Longitudinal Studies
2
2018
1019
0.140
Why?
Vascular Surgical Procedures
1
2017
148
0.140
Why?
Proto-Oncogene Proteins pp60(c-src)
2
1993
12
0.140
Why?
Electric Impedance
1
2016
104
0.140
Why?
Antineoplastic Agents
4
2016
2360
0.140
Why?
Guideline Adherence
4
2017
224
0.140
Why?
Disease-Free Survival
4
2017
1204
0.140
Why?
Cell Line, Tumor
10
2018
2427
0.130
Why?
Tetradecanoylphorbol Acetate
2
2006
137
0.130
Why?
Drug Resistance
1
2016
256
0.130
Why?
Gastroesophageal Reflux
2
2015
117
0.130
Why?
Lymphoma
2
2002
262
0.130
Why?
Pneumonia, Viral
1
2020
315
0.130
Why?
Feasibility Studies
4
2016
751
0.130
Why?
Academic Medical Centers
2
2007
378
0.130
Why?
Coronavirus Infections
1
2020
300
0.130
Why?
Benchmarking
2
2008
78
0.130
Why?
Cell Division
6
2007
696
0.130
Why?
Membrane Proteins
4
2005
1201
0.120
Why?
Remission, Spontaneous
1
2014
53
0.120
Why?
Cholecystectomy, Laparoscopic
1
2014
50
0.120
Why?
Gene Frequency
1
2016
677
0.120
Why?
Herniorrhaphy
1
2015
79
0.120
Why?
Mitogen-Activated Protein Kinases
2
2005
224
0.120
Why?
Hernia, Inguinal
1
2015
67
0.120
Why?
Genetic Predisposition to Disease
3
2018
2272
0.120
Why?
Operating Rooms
1
2014
126
0.120
Why?
Magnetic Resonance Imaging
4
2015
3366
0.110
Why?
Neutropenia
2
2011
215
0.110
Why?
Cost-Benefit Analysis
3
2017
453
0.110
Why?
Margins of Excision
3
2018
39
0.110
Why?
Interleukin-23
1
2013
54
0.110
Why?
Quality Improvement
1
2017
427
0.110
Why?
Trisaccharides
1
2012
12
0.110
Why?
Immunotherapy, Active
1
2012
15
0.110
Why?
Interleukin-12
1
2013
109
0.110
Why?
Hemorrhage
1
2014
267
0.110
Why?
Quality Control
1
2012
117
0.110
Why?
Urinary Bladder Neoplasms
2
1993
383
0.110
Why?
Practice Guidelines as Topic
1
2020
1037
0.110
Why?
Jaundice, Obstructive
1
2012
10
0.110
Why?
Radiopharmaceuticals
2
2012
180
0.110
Why?
Nausea
2
2011
175
0.110
Why?
Gallbladder
1
2012
30
0.110
Why?
Adipocytes, White
1
2012
2
0.110
Why?
Ischemic Preconditioning
1
2012
37
0.110
Why?
Electroporation
1
2012
57
0.100
Why?
Arthritis, Psoriatic
1
2012
32
0.100
Why?
Gene Deletion
1
2013
337
0.100
Why?
Protein-Tyrosine Kinases
2
1993
302
0.100
Why?
Serpins
1
2012
29
0.100
Why?
Organoplatinum Compounds
3
2017
94
0.100
Why?
Leucovorin
3
2017
218
0.100
Why?
Bile Ducts, Intrahepatic
1
2012
70
0.100
Why?
Ablation Techniques
1
2012
34
0.100
Why?
Spectrum Analysis
1
2012
118
0.100
Why?
Operative Time
3
2017
127
0.100
Why?
Esophagus
1
2012
102
0.100
Why?
Nerve Growth Factors
1
2012
63
0.100
Why?
Sex Factors
4
2014
1053
0.100
Why?
Radiology, Interventional
1
2012
68
0.100
Why?
Ultrasonography, Interventional
1
2012
121
0.100
Why?
Lipoxygenase Inhibitors
2
2008
33
0.100
Why?
Photochemotherapy
1
2012
97
0.100
Why?
Microspheres
2
2009
101
0.100
Why?
Disease Progression
5
2018
1534
0.100
Why?
Camptothecin
3
2017
189
0.100
Why?
Arteries
1
2012
177
0.100
Why?
Leukopenia
1
2011
65
0.100
Why?
Ileus
1
2011
9
0.100
Why?
Cancer Vaccines
1
2012
156
0.100
Why?
Clinical Trials as Topic
1
2016
1169
0.100
Why?
Abdominal Abscess
1
2011
22
0.100
Why?
Brachytherapy
1
2012
119
0.100
Why?
Proto-Oncogene Proteins p21(ras)
1
2012
154
0.100
Why?
Biopsy
5
2009
1163
0.100
Why?
Appointments and Schedules
1
2011
53
0.090
Why?
Chromosome Aberrations
1
2012
387
0.090
Why?
Methotrexate
1
2011
249
0.090
Why?
Immunohistochemistry
9
2009
1759
0.090
Why?
Receptors, Leukotriene B4
2
2007
6
0.090
Why?
Treatment Failure
2
2009
286
0.090
Why?
Intestinal Obstruction
1
2011
87
0.090
Why?
Cyclosporine
1
2011
236
0.090
Why?
Health Services Needs and Demand
1
2011
102
0.090
Why?
G2 Phase
2
2006
34
0.090
Why?
Mucin 5AC
1
2009
8
0.090
Why?
Mucin-2
1
2009
12
0.090
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2012
243
0.090
Why?
Mucin-1
1
2009
44
0.090
Why?
Spleen
1
2011
430
0.090
Why?
Waiting Lists
1
2011
175
0.090
Why?
Pancreatic Ducts
2
1999
26
0.090
Why?
Learning Curve
2
2022
18
0.090
Why?
Adrenal Cortex Hormones
1
2021
261
0.090
Why?
Pancreatitis, Chronic
1
2010
49
0.090
Why?
Duodenal Neoplasms
1
2009
19
0.090
Why?
Sarcoma
2
2002
215
0.090
Why?
Hypertension
1
2018
1142
0.090
Why?
Polymorphism, Genetic
1
2013
819
0.090
Why?
Vitamin D
3
2018
261
0.090
Why?
Remission Induction
1
2011
722
0.090
Why?
Safety
2
2010
152
0.090
Why?
Clinical Competence
3
2023
756
0.090
Why?
Maximum Tolerated Dose
2
2010
270
0.090
Why?
Illinois
3
2015
462
0.090
Why?
Radiotherapy Dosage
2
2011
468
0.080
Why?
DNA Methylation
3
2010
630
0.080
Why?
Ischemia
1
2011
243
0.080
Why?
Breast Neoplasms
3
1999
2904
0.080
Why?
Carcinoma, Acinar Cell
1
2008
11
0.080
Why?
Animals
11
2016
26706
0.080
Why?
S Phase
2
2007
63
0.080
Why?
Research Design
3
2009
594
0.080
Why?
Chicago
2
2020
1380
0.080
Why?
Hepatocyte Nuclear Factor 1-beta
1
2008
34
0.080
Why?
Neoplasms, Squamous Cell
1
2008
19
0.080
Why?
Socioeconomic Factors
2
2008
567
0.080
Why?
Curriculum
2
2023
542
0.080
Why?
Esophagogastric Junction
1
2008
34
0.080
Why?
Gastroscopy
1
2007
23
0.080
Why?
Sentinel Lymph Node Biopsy
1
2008
68
0.080
Why?
Diagnostic Imaging
1
2012
468
0.080
Why?
Gastrointestinal Stromal Tumors
1
2007
23
0.080
Why?
Adenocarcinoma, Clear Cell
1
2008
62
0.080
Why?
Apoptosis
4
2008
1689
0.080
Why?
Catheter Ablation
1
2010
233
0.080
Why?
Leukotriene Antagonists
1
2007
25
0.080
Why?
Disease Models, Animal
2
2008
2243
0.070
Why?
Referral and Consultation
1
2010
328
0.070
Why?
Apigenin
1
2006
7
0.070
Why?
Hemothorax
1
1987
15
0.070
Why?
Stilbenes
1
2007
25
0.070
Why?
Dose-Response Relationship, Drug
4
2006
1960
0.070
Why?
Hospitals, Teaching
1
2007
116
0.070
Why?
Quality Assurance, Health Care
1
2008
219
0.070
Why?
Workload
2
2023
128
0.070
Why?
Adenoma, Islet Cell
2
2007
28
0.070
Why?
Mitosis
1
2006
153
0.070
Why?
Bone Morphogenetic Proteins
1
2007
126
0.070
Why?
Guidelines as Topic
1
2007
162
0.070
Why?
Leukotriene B4
1
2005
14
0.070
Why?
Depsipeptides
1
2006
29
0.070
Why?
Neoplasm Seeding
1
2005
16
0.070
Why?
Surgical Flaps
1
2008
241
0.070
Why?
Patient Compliance
1
2007
228
0.070
Why?
Ultrasonography
2
2012
692
0.070
Why?
Epithelium
1
2006
319
0.070
Why?
Odds Ratio
1
2007
679
0.070
Why?
Cystadenocarcinoma
2
1995
12
0.070
Why?
Phosphorylation
4
2006
1106
0.070
Why?
Bariatric Surgery
1
2008
194
0.070
Why?
Cyclooxygenase 2
1
2005
100
0.060
Why?
Blotting, Western
4
2012
786
0.060
Why?
Postoperative Care
2
2017
221
0.060
Why?
Reference Values
2
1999
673
0.060
Why?
Antineoplastic Agents, Phytogenic
1
2007
276
0.060
Why?
Tissue Inhibitor of Metalloproteinase-1
1
2004
17
0.060
Why?
Diagnostic Errors
1
2006
158
0.060
Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
189
0.060
Why?
Actuarial Analysis
2
2002
66
0.060
Why?
Phosphatidylinositol 3-Kinases
1
2005
262
0.060
Why?
Drug Synergism
1
2005
303
0.060
Why?
Pilot Projects
2
2017
840
0.060
Why?
Gene Expression Regulation, Enzymologic
1
2005
215
0.060
Why?
Fatal Outcome
1
2004
295
0.060
Why?
Infusions, Intra-Arterial
2
2008
34
0.060
Why?
RNA, Messenger
4
2018
1988
0.060
Why?
Melanoma
1
2008
459
0.060
Why?
Soft Tissue Neoplasms
1
2004
126
0.060
Why?
Factor V
1
2023
10
0.060
Why?
Prothrombin
1
2023
18
0.060
Why?
Piperacillin
1
2023
7
0.060
Why?
Penicillanic Acid
1
2023
11
0.060
Why?
Radiography
1
2005
808
0.060
Why?
Cholecystectomy
1
2023
18
0.060
Why?
Demography
1
2004
177
0.060
Why?
Social Class
1
2004
128
0.060
Why?
Protein Kinases
2
1996
209
0.060
Why?
Capillaries
1
2003
91
0.060
Why?
Skin Neoplasms
1
2008
546
0.060
Why?
Anastomosis, Roux-en-Y
1
2023
26
0.060
Why?
Case-Control Studies
2
2006
1809
0.060
Why?
Cyclin A
3
2007
28
0.060
Why?
Hyaluronan Receptors
1
2002
36
0.060
Why?
Hyperparathyroidism
1
2002
67
0.060
Why?
Cytoreduction Surgical Procedures
1
2023
73
0.050
Why?
Heparin, Low-Molecular-Weight
1
2022
29
0.050
Why?
Colectomy
3
2008
167
0.050
Why?
Carcinoembryonic Antigen
2
1999
41
0.050
Why?
Parathyroid Neoplasms
1
2002
55
0.050
Why?
Parathyroidectomy
1
2002
78
0.050
Why?
Bile
1
2022
57
0.050
Why?
Endoscopy
1
2005
332
0.050
Why?
Regression Analysis
2
2017
596
0.050
Why?
Immunoenzyme Techniques
3
2008
303
0.050
Why?
Bone Neoplasms
1
2004
321
0.050
Why?
Cadherins
1
2002
153
0.050
Why?
Cardiac Surgical Procedures
1
1987
462
0.050
Why?
Biopsy, Needle
2
2009
234
0.050
Why?
Cell Cycle Proteins
2
2006
388
0.050
Why?
Thymidylate Synthase
1
2001
13
0.050
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2001
62
0.050
Why?
Consensus
1
2023
336
0.050
Why?
Credentialing
1
2001
13
0.050
Why?
Outpatient Clinics, Hospital
1
2001
23
0.050
Why?
Marketing of Health Services
1
2001
15
0.050
Why?
DNA, Neoplasm
2
2006
265
0.050
Why?
Midwestern United States
1
2001
76
0.050
Why?
Cisplatin
3
2011
612
0.050
Why?
Dose-Response Relationship, Radiation
1
2000
188
0.050
Why?
United Kingdom
1
2020
164
0.050
Why?
Biological Specimen Banks
1
2020
65
0.050
Why?
Sensitivity and Specificity
2
2009
1991
0.050
Why?
Neovascularization, Pathologic
1
2002
356
0.050
Why?
Surgical Procedures, Operative
2
2011
182
0.050
Why?
Sequence Deletion
1
2020
206
0.050
Why?
Leiomyomatosis
1
2000
12
0.040
Why?
Florida
1
2020
55
0.040
Why?
Morbidity
1
2020
148
0.040
Why?
Pharyngeal Neoplasms
1
1999
15
0.040
Why?
Infusions, Intravenous
1
2000
429
0.040
Why?
Untranslated Regions
1
2019
19
0.040
Why?
Bronchi
1
2020
229
0.040
Why?
Nuclear Matrix-Associated Proteins
1
1999
13
0.040
Why?
ROC Curve
2
2014
752
0.040
Why?
Antigens, Nuclear
1
1999
25
0.040
Why?
Reagent Kits, Diagnostic
1
1999
39
0.040
Why?
Anticoagulants
1
2022
407
0.040
Why?
Adenomatous Polyposis Coli
1
1999
39
0.040
Why?
Open Reading Frames
1
2019
117
0.040
Why?
Immunoassay
1
1999
92
0.040
Why?
Congresses as Topic
1
2020
116
0.040
Why?
Genetic Counseling
1
1999
100
0.040
Why?
Program Evaluation
1
2020
297
0.040
Why?
Tumor Suppressor Protein p53
1
2001
381
0.040
Why?
Pharmacogenomic Testing
1
2019
97
0.040
Why?
Class II Phosphatidylinositol 3-Kinases
1
2018
8
0.040
Why?
Autoantigens
1
1999
127
0.040
Why?
Lymphoma, Non-Hodgkin
1
2020
261
0.040
Why?
Statistics, Nonparametric
2
2009
308
0.040
Why?
Chi-Square Distribution
2
2009
364
0.040
Why?
Flow Cytometry
3
2007
680
0.040
Why?
Intention to Treat Analysis
1
2018
72
0.040
Why?
Filgrastim
1
2017
56
0.040
Why?
Gastrointestinal Diseases
1
1999
146
0.040
Why?
Anti-Bacterial Agents
1
2023
747
0.040
Why?
Cryosurgery
1
1998
41
0.040
Why?
Receptor, Notch1
1
2018
94
0.040
Why?
Tumor Cells, Cultured
3
2008
1041
0.040
Why?
Radiography, Abdominal
1
2017
68
0.040
Why?
Blood Loss, Surgical
1
2017
112
0.040
Why?
Neoplasms, Second Primary
1
2000
252
0.040
Why?
Hernia, Ventral
1
2017
24
0.040
Why?
Incisional Hernia
1
2017
17
0.040
Why?
Prolactinoma
1
1997
8
0.040
Why?
Nucleic Acid Synthesis Inhibitors
2
2007
15
0.040
Why?
Cyclin E
2
2007
27
0.040
Why?
Clinical Trials, Phase II as Topic
1
1998
176
0.040
Why?
Cyclin B
2
2006
17
0.040
Why?
Betacoronavirus
1
2020
257
0.040
Why?
Animals, Genetically Modified
1
1997
182
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2008
881
0.040
Why?
Genetic Engineering
1
1997
115
0.040
Why?
Breast Neoplasms, Male
1
1997
30
0.040
Why?
Serum Albumin
1
2017
130
0.040
Why?
Blood Transfusion
1
2017
157
0.040
Why?
Models, Economic
1
2017
60
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
74
0.040
Why?
Shock, Septic
1
2017
102
0.040
Why?
Atrophy
1
2017
117
0.040
Why?
Pituitary Neoplasms
1
1997
62
0.040
Why?
Molecular Sequence Data
4
2005
3035
0.040
Why?
Body Composition
1
2016
68
0.040
Why?
Oligonucleotide Array Sequence Analysis
2
2010
691
0.030
Why?
Neoplasms, Multiple Primary
1
1997
100
0.030
Why?
Promoter Regions, Genetic
1
1999
943
0.030
Why?
Capecitabine
1
2016
96
0.030
Why?
Vascular Endothelial Growth Factor A
1
2018
411
0.030
Why?
Zonula Occludens-2 Protein
3
2000
11
0.030
Why?
Antineoplastic Agents, Immunological
1
2018
185
0.030
Why?
Data Collection
1
2017
372
0.030
Why?
Drug Therapy, Combination
1
2018
895
0.030
Why?
Cystadenoma, Mucinous
1
1995
7
0.030
Why?
Cystadenoma, Serous
1
1995
15
0.030
Why?
Butadienes
2
2005
33
0.030
Why?
RNA Helicases
1
1996
35
0.030
Why?
Flavonoids
2
2006
85
0.030
Why?
Mice
5
2012
11439
0.030
Why?
Genetic Heterogeneity
1
2015
62
0.030
Why?
Heterografts
1
2015
98
0.030
Why?
Genes, Tumor Suppressor
1
1996
157
0.030
Why?
Polyethylene Glycols
1
2017
364
0.030
Why?
Cost Control
1
2015
44
0.030
Why?
Nitriles
2
2005
149
0.030
Why?
Mice, Nude
2
2008
789
0.030
Why?
Keratin-19
1
2014
9
0.030
Why?
Cystadenoma
1
1994
19
0.030
Why?
Radiotherapy, Intensity-Modulated
1
2016
173
0.030
Why?
Inhibitor of Apoptosis Proteins
1
2014
33
0.030
Why?
Proton Pump Inhibitors
1
2015
32
0.030
Why?
Ki-67 Antigen
1
2014
64
0.030
Why?
Patient Care Planning
1
2015
81
0.030
Why?
Proto-Oncogene Proteins c-kit
1
2014
80
0.030
Why?
Neoplasm Regression, Spontaneous
1
2014
7
0.030
Why?
Perioperative Care
1
2016
162
0.030
Why?
Clinical Trials, Phase III as Topic
1
2015
172
0.030
Why?
Adipose Tissue
1
2016
241
0.030
Why?
Gene Expression
2
2015
1286
0.030
Why?
Mastectomy
1
1996
243
0.030
Why?
Surgical Mesh
1
2015
116
0.030
Why?
Pandemics
1
2020
737
0.030
Why?
Double-Blind Method
1
2018
1824
0.030
Why?
Breast
1
1996
288
0.030
Why?
Postoperative Period
1
2014
302
0.030
Why?
Bone Density Conservation Agents
1
2014
45
0.030
Why?
DNA
2
2010
1295
0.030
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2015
231
0.030
Why?
Mammography
1
1996
463
0.030
Why?
Phosphopyruvate Hydratase
1
1993
39
0.030
Why?
Body Mass Index
1
2016
768
0.030
Why?
Antigen-Antibody Complex
1
1993
87
0.030
Why?
Jejunostomy
1
2012
14
0.030
Why?
Ligation
1
2012
51
0.030
Why?
Population Surveillance
1
2014
219
0.030
Why?
Gastric Emptying
1
2012
24
0.030
Why?
Blood Sedimentation
1
2012
13
0.030
Why?
Analysis of Variance
1
2014
911
0.030
Why?
Synovial Membrane
1
2012
28
0.030
Why?
Genetic Variation
1
2019
1351
0.030
Why?
Celiac Artery
1
2012
25
0.030
Why?
Cell Transformation, Neoplastic
1
2015
427
0.030
Why?
Immunoblotting
1
1993
268
0.030
Why?
Bone Resorption
1
2012
42
0.030
Why?
Rats
3
2005
4004
0.030
Why?
Rats, Sprague-Dawley
2
2005
1222
0.030
Why?
Practice Patterns, Physicians'
1
2017
584
0.030
Why?
Enteral Nutrition
1
2012
103
0.030
Why?
Matrix Metalloproteinase 2
1
2012
44
0.030
Why?
Cricetinae
2
2005
560
0.030
Why?
Adiposity
1
2012
70
0.030
Why?
Matrix Metalloproteinase 9
1
2012
79
0.030
Why?
Constriction, Pathologic
1
2012
212
0.030
Why?
Mitomycin
1
2011
29
0.020
Why?
C-Reactive Protein
1
2012
190
0.020
Why?
Anastomotic Leak
1
2012
96
0.020
Why?
Benzodiazepines
1
2011
65
0.020
Why?
Randomized Controlled Trials as Topic
1
2015
864
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2012
276
0.020
Why?
Eye Proteins
1
2012
128
0.020
Why?
Genome-Wide Association Study
1
2018
1621
0.020
Why?
Validation Studies as Topic
1
2010
16
0.020
Why?
Intestinal Perforation
1
1990
34
0.020
Why?
Tissue Array Analysis
1
2010
124
0.020
Why?
Health Care Surveys
1
2011
278
0.020
Why?
Metaplasia
1
2009
37
0.020
Why?
Polymorphism, Single Nucleotide
1
2018
2357
0.020
Why?
Forecasting
1
2011
305
0.020
Why?
Obesity
1
2016
964
0.020
Why?
Sphincterotomy, Endoscopic
1
2009
9
0.020
Why?
CD11 Antigens
1
2009
14
0.020
Why?
Cause of Death
1
2010
277
0.020
Why?
Receptors, Androgen
1
2009
113
0.020
Why?
Radiation Injuries
1
1990
156
0.020
Why?
Receptors, Tumor Necrosis Factor
1
2009
89
0.020
Why?
Masoprocol
1
2008
3
0.020
Why?
Microarray Analysis
1
2009
96
0.020
Why?
Thymidine
1
2008
59
0.020
Why?
Quality of Life
1
2017
1587
0.020
Why?
Periodic Acid-Schiff Reaction
1
2008
6
0.020
Why?
Data Interpretation, Statistical
1
2010
297
0.020
Why?
Fluorescent Antibody Technique, Direct
1
2008
10
0.020
Why?
Pelvic Exenteration
1
2008
5
0.020
Why?
Amino Acid Sequence
2
2005
2065
0.020
Why?
Intestinal Fistula
1
2008
30
0.020
Why?
Probability
1
2009
354
0.020
Why?
Perineum
1
2008
36
0.020
Why?
Lung Neoplasms
1
2020
2262
0.020
Why?
Antigens, Tumor-Associated, Carbohydrate
1
2007
11
0.020
Why?
Tomography, Emission-Computed
1
2008
102
0.020
Why?
Mice, Transgenic
2
2005
1557
0.020
Why?
Professional Practice
1
2008
46
0.020
Why?
Abdominal Cavity
1
2008
18
0.020
Why?
Gastrointestinal Hemorrhage
1
1990
230
0.020
Why?
Gastric Outlet Obstruction
1
2007
10
0.020
Why?
Hospital Mortality
1
2010
350
0.020
Why?
Intestinal Mucosa
1
1993
797
0.020
Why?
Genes, bcl-2
1
2007
16
0.020
Why?
Caspase 7
1
2007
15
0.020
Why?
Cytochromes c
1
2007
27
0.020
Why?
Cholestasis
1
2007
47
0.020
Why?
Cyclin-Dependent Kinase 2
1
2007
25
0.020
Why?
Caspase 9
1
2007
48
0.020
Why?
Asthenia
1
2007
4
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2007
36
0.020
Why?
bcl-2-Associated X Protein
1
2007
47
0.020
Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2007
35
0.020
Why?
Poly(ADP-ribose) Polymerases
1
2007
48
0.020
Why?
Growth Differentiation Factor 15
1
2007
9
0.020
Why?
Dactinomycin
1
2007
36
0.020
Why?
cdc25 Phosphatases
1
2006
18
0.020
Why?
Immunoglobulin G
1
2009
457
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
458
0.020
Why?
Caspase 3
1
2007
159
0.020
Why?
Mice, Knockout
1
2012
1944
0.020
Why?
Surgical Wound Dehiscence
1
1987
37
0.020
Why?
In Vitro Techniques
1
2008
990
0.020
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2007
72
0.020
Why?
Vagina
1
2008
161
0.020
Why?
CDC2 Protein Kinase
1
2006
45
0.020
Why?
Cyclin B1
1
2006
17
0.020
Why?
Headache
1
2007
73
0.020
Why?
Maleimides
1
2006
29
0.020
Why?
Mitogen-Activated Protein Kinase 3
1
2006
69
0.020
Why?
Mitogen-Activated Protein Kinase 1
1
2006
75
0.020
Why?
MAP Kinase Kinase Kinases
1
2006
41
0.020
Why?
Mice, Inbred BALB C
1
2008
1059
0.020
Why?
Vomiting
1
2008
193
0.020
Why?
Cell Nucleus
1
2008
581
0.020
Why?
Nitrobenzenes
1
2005
11
0.020
Why?
Enzyme Activation
1
2007
693
0.020
Why?
Nitrosamines
1
2005
8
0.020
Why?
Cyclooxygenase 2 Inhibitors
1
2005
33
0.020
Why?
Positron-Emission Tomography
1
2007
329
0.020
Why?
Electrophoresis, Polyacrylamide Gel
1
2005
268
0.020
Why?
Cell Growth Processes
1
2005
83
0.020
Why?
Base Sequence
2
1999
2335
0.020
Why?
Tumor Necrosis Factor-alpha
1
2009
685
0.020
Why?
Protein Kinase C
1
2006
270
0.020
Why?
Androstadienes
1
2005
72
0.020
Why?
NIH 3T3 Cells
1
2005
105
0.020
Why?
Disease Management
1
2007
328
0.020
Why?
Culture Media, Conditioned
1
2005
104
0.020
Why?
Coculture Techniques
1
2005
164
0.020
Why?
Carcinogens
1
2005
108
0.020
Why?
PPAR gamma
1
2005
66
0.020
Why?
Transfection
1
2007
898
0.020
Why?
RNA, Small Interfering
1
2007
547
0.020
Why?
Quinolines
1
2005
95
0.020
Why?
Random Allocation
1
2005
332
0.020
Why?
Indoles
1
2006
318
0.020
Why?
Neoplasm Transplantation
1
2005
392
0.020
Why?
Sequence Homology, Amino Acid
1
2005
416
0.020
Why?
Signal Transduction
2
2005
3267
0.020
Why?
Green Fluorescent Proteins
1
2005
306
0.020
Why?
Up-Regulation
1
2007
717
0.010
Why?
Pregnancy Complications
1
2007
337
0.010
Why?
Neoplasm Proteins
1
2007
532
0.010
Why?
Administration, Oral
1
2005
683
0.010
Why?
Cell Survival
1
2006
971
0.010
Why?
Sulfonamides
1
2005
300
0.010
Why?
Enzyme Inhibitors
1
2005
639
0.010
Why?
Transcription, Genetic
1
2007
1138
0.010
Why?
Protein Kinase Inhibitors
1
2006
589
0.010
Why?
Thyroid Gland
1
2002
270
0.010
Why?
Cell Differentiation
1
2007
1471
0.010
Why?
Cell Line
1
2006
2476
0.010
Why?
Biomarkers
1
2006
1722
0.010
Why?
Cells, Cultured
1
2005
2839
0.010
Why?
Vulvar Neoplasms
1
2000
20
0.010
Why?
Technetium Tc 99m Sulfur Colloid
1
1999
11
0.010
Why?
Pregnancy
1
2007
2901
0.010
Why?
Palpation
1
1999
18
0.010
Why?
Coloring Agents
1
1999
64
0.010
Why?
Protein Isoforms
1
2000
272
0.010
Why?
Introns
1
2000
290
0.010
Why?
Blotting, Northern
1
1999
258
0.010
Why?
Axilla
1
1999
99
0.010
Why?
Radionuclide Imaging
1
1999
220
0.010
Why?
Image Processing, Computer-Assisted
1
2005
1205
0.010
Why?
Exons
1
2000
452
0.010
Why?
Medical Staff, Hospital
1
1999
107
0.010
Why?
Proliferating Cell Nuclear Antigen
1
1997
66
0.010
Why?
Heart Failure
1
2007
1207
0.010
Why?
Gynecomastia
1
1997
8
0.010
Why?
Mastectomy, Modified Radical
1
1997
6
0.010
Why?
Genetic Techniques
1
1997
72
0.010
Why?
Microscopy, Electron
1
1997
504
0.010
Why?
Recurrence
1
1999
1139
0.010
Why?
RNA, Double-Stranded
1
1996
22
0.010
Why?
Hyperplasia
1
1996
148
0.010
Why?
DEAD-box RNA Helicases
1
1996
62
0.010
Why?
eIF-2 Kinase
1
1995
46
0.010
Why?
Precancerous Conditions
1
1996
196
0.010
Why?
Ovarian Neoplasms
1
1993
744
0.000
Why?
Talamonti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (729)
Explore
_
Co-Authors (41)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_